
Kotak Alternate Asset Managers, via its Kotak Life Science Fund I, has invested ₹40 crore in Mediversal Healthcare to scale up medical infrastructure in Bihar and nearby regions. This move targets enhancing access to affordable, quality healthcare services in underserved parts of Eastern India.
Kotak Life Science Fund I, known for supporting high-impact healthcare ventures, has channelled ₹40 crore into Mediversal Healthcare. The strategic investment, complemented by participation from Asha Ventures, aims to fuel both organic and inorganic expansion. Mediversal plans to extend its footprint across Bihar and adjacent districts, strengthening its commitment to reliable and dignified healthcare delivery.
Founded in 2020 by Navneet Ranjan, Bhanu Pratap, and Jayant Gandhi, Mediversal operates a 200+ bed multi-speciality hospital in Patna.
The firm intends to broaden its presence across rural and urban Eastern India. Using this funding, Mediversal will open several new hospitals and invest in its digital healthcare infrastructure to streamline scalability and maintain clinical standards across all locations.
Mediversal promotes a patient-centric model focusing on affordability without compromising clinical excellence.
The hospital group already has significant milestones to its name, including full NABH Certification, CAHO ACE accreditation, and compliance with IDCCM & IDCCN standards placing it among a select group of Eastern Indian hospitals meeting such criteria.
Read More: India Deep Tech Alliance to Invest up to $15 Million in AI, Space, and Defence Startups!
The funding will accelerate Mediversal's vision to create an East India-centred healthcare ecosystem.
Conclusion
Kotak has invested ₹40 crore in Mediversal Healthcare. The investment is intended to support the growth of healthcare infrastructure in Eastern India, with a focus on scalable systems and community engagement.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Mutual Fund investments are subject to market risks, read all scheme-related documents carefully.
Published on: Nov 14, 2025, 12:20 PM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates